Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Diabetes

Date Submitted: Nov 14, 2022
Date Accepted: Jun 10, 2023

The final, peer-reviewed published version of this preprint can be found here:

Experiences and Perceptions of Telehealth Visits in Diabetes Care During and After the COVID-19 Pandemic Among Adults With Type 2 Diabetes and Their Providers: Qualitative Study

Sun CA, Shenk Z, Renda S, Maruthur NM, Zheng S, Perrin N, Levin S, Han HR

Experiences and Perceptions of Telehealth Visits in Diabetes Care During and After the COVID-19 Pandemic Among Adults With Type 2 Diabetes and Their Providers: Qualitative Study

JMIR Diabetes 2023;8:e44283

DOI: 10.2196/44283

PMID: 37463021

PMCID: 10394605

Experiences and Perceptions of Telehealth Visits in Diabetes Care During/Post COVID-19 Pandemic Among Adults with Type 2 Diabetes and Their Providers: A Qualitative Study

  • Chun-An Sun; 
  • Zachary Shenk; 
  • Susan Renda; 
  • Nisa M. Maruthur; 
  • Stanley Zheng; 
  • Nancy Perrin; 
  • Scott Levin; 
  • Hae-Ra Han

ABSTRACT

Background:

Since the coronavirus disease-2019 pandemic, telehealth has been widely adopted in outpatient settings in the United States. Although telehealth visits are publicly accepted in different settings, little is known after wide adoption of telehealth from the perspectives of adults living with type 2 diabetes mellitus (T2DM) and their providers.

Objective:

To enhance user experience and promote care continuity, it is important to explore patient’s and providers’ experiences and perceptions of telehealth visits in T2DM care.

Methods:

As the second phase of a multi-method study to understand missed appointments among adults with T2DM, we conducted semi-structured individual in-depth phone or zoom interviews with 23 adults with T2DM (61% women, mean age 55.1, range 35-77 years, SD 14.4 years) and 10 providers from diabetes clinics in a tertiary academic medical center in Maryland. Interviews were audio-recorded, transcribed, and analyzed using a thematic content analysis by the research team.

Results:

Adults with T2DM and their providers generally reported positive experiences with telehealth visits for diabetes care with some technical challenges, resulting in the needs for in-person visits. Three themes were identified: “Perceived Benefits of Telehealth Visits” shared by both patients and providers, “Perceived Technological Challenges of Telehealth Visits” shared by both patients and providers, and “Clinical Implications of telehealth visits” mainly from providers’ perspectives with some patients’ inputs.

Conclusions:

Telehealth is generally received positively in diabetes care with some challenges persisted, which might compromise the quality of the diabetes care. Telehealth technology design must corporate user experience and user-centered design to optimize telehealth use in diabetes care. Future research to investigate the ideal balance between in-person and telehealth visits in diabetes care is warranted to promote the quality of diabetes care to optimize diabetes outcomes.


 Citation

Please cite as:

Sun CA, Shenk Z, Renda S, Maruthur NM, Zheng S, Perrin N, Levin S, Han HR

Experiences and Perceptions of Telehealth Visits in Diabetes Care During and After the COVID-19 Pandemic Among Adults With Type 2 Diabetes and Their Providers: Qualitative Study

JMIR Diabetes 2023;8:e44283

DOI: 10.2196/44283

PMID: 37463021

PMCID: 10394605

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.